These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 10359027

  • 21. Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
    Cacciarelli TV, Green M, Jaffe R, Mazariegos GV, Jain A, Fung JJ, Reyes J.
    Transplantation; 1998 Oct 27; 66(8):1047-52. PubMed ID: 9808490
    [Abstract] [Full Text] [Related]

  • 22. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols.
    Treede H, Klepetko W, Reichenspurner H, Zuckermann A, Meiser B, Birsan T, Wisser W, Reichert B, Munich and Vienna Lung Transplant Group.
    J Heart Lung Transplant; 2001 May 27; 20(5):511-7. PubMed ID: 11343977
    [Abstract] [Full Text] [Related]

  • 23. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A, Mazariegos G, Pokharna R, Parizhskaya M, Kashyap R, Kosmach-Park B, Smith A, Fung JJ, Reyes J.
    Transplantation; 2003 Apr 15; 75(7):1020-5. PubMed ID: 12698091
    [Abstract] [Full Text] [Related]

  • 24. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
    Newell KA, Alonso EM, Whitington PF, Bruce DS, Millis JM, Piper JB, Woodle ES, Kelly SM, Koeppen H, Hart J, Rubin CM, Thistlethwaite JR.
    Transplantation; 1996 Aug 15; 62(3):370-5. PubMed ID: 8779685
    [Abstract] [Full Text] [Related]

  • 25. Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients.
    Cacciarelli TV, Reyes J, Jaffe R, Mazariegos GV, Jain A, Fung JJ, Green M.
    Pediatr Transplant; 2001 Oct 15; 5(5):359-64. PubMed ID: 11560756
    [Abstract] [Full Text] [Related]

  • 26. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R.
    Pediatr Transplant; 2006 Dec 15; 10(8):938-42. PubMed ID: 17096762
    [Abstract] [Full Text] [Related]

  • 27. Infection rates in tacrolimus versus cyclosporine-treated pediatric kidney transplant recipients on a rapid discontinuation of prednisone protocol: 1-year analysis.
    Kizilbash SJ, Rheault MN, Bangdiwala A, Matas A, Chinnakotla S, Chavers BM.
    Pediatr Transplant; 2017 Jun 15; 21(4):. PubMed ID: 28371243
    [Abstract] [Full Text] [Related]

  • 28. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ, Rossi AF, Courtney M, Gelb BD.
    J Heart Lung Transplant; 1998 Dec 15; 17(12):1195-200. PubMed ID: 9883760
    [Abstract] [Full Text] [Related]

  • 29. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 15; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 30. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.
    McKee M, Segev D, Wise B, Case B, Neu A, Fivush B, Colombani P.
    J Pediatr Surg; 1997 May 15; 32(5):688-90. PubMed ID: 9165452
    [Abstract] [Full Text] [Related]

  • 31. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE, Gohh R, Shaffer D, Crosson A, Madras PN, Sahyoun AI, Monaco AP.
    Transplantation; 1997 Mar 27; 63(6):845-8. PubMed ID: 9089224
    [Abstract] [Full Text] [Related]

  • 32. Conversion from cyclosporine A to tacrolimus in pediatric kidney transplant recipients with chronic rejection: changes in the immune responses.
    Ferraris JR, Tambutti ML, Cardoni RL, Prigoshin N.
    Transplantation; 2004 Feb 27; 77(4):532-7. PubMed ID: 15084930
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients.
    Onsager DR, Canver CC, Jahania MS, Welter D, Michalski M, Hoffman AM, Mentzer RM, Love RB.
    J Heart Lung Transplant; 1999 May 27; 18(5):448-55. PubMed ID: 10363689
    [Abstract] [Full Text] [Related]

  • 34. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
    Neuhaus P, Blumhardt G, Bechstein WO, Platz KP, Jonas S, Mueller AR, Langrehr JM, Lohmann R, Schattenfroh N, Knoop M.
    Transplantation; 1995 Jan 15; 59(1):31-40. PubMed ID: 7530868
    [Abstract] [Full Text] [Related]

  • 35. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
    Filler G, Webb NJ, Milford DV, Watson AR, Gellermann J, Tyden G, Grenda R, Vondrak K, Hughes D, Offner G, Griebel M, Brekke IB, McGraw M, Balzar E, Friman S, Trompeter R.
    Pediatr Transplant; 2005 Aug 15; 9(4):498-503. PubMed ID: 16048603
    [Abstract] [Full Text] [Related]

  • 36. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine.
    Stegall MD, Simon M, Wachs ME, Chan L, Nolan C, Kam I.
    Transplantation; 1997 Dec 27; 64(12):1695-700. PubMed ID: 9422404
    [Abstract] [Full Text] [Related]

  • 37. Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation.
    Jain A, Mazariegos G, Kashyap R, Marsh W, Khanna A, Iurlano K, Fung J, Reyes J.
    Pediatr Transplant; 2001 Apr 27; 5(2):93-8. PubMed ID: 11328546
    [Abstract] [Full Text] [Related]

  • 38. Epstein-Barr virus infections in children after transplantation of the small intestine.
    Finn L, Reyes J, Bueno J, Yunis E.
    Am J Surg Pathol; 1998 Mar 27; 22(3):299-309. PubMed ID: 9500771
    [Abstract] [Full Text] [Related]

  • 39. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H, Moal V, Indreies M, Purgus R, Loundou A, Burtey S, Brunet P, Moussi-Frances J, Daniel L, Dussol B, Berland Y.
    Transplantation; 2012 Feb 27; 93(4):437-43. PubMed ID: 22228415
    [Abstract] [Full Text] [Related]

  • 40. Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus.
    Sindhi R, Webber S, Venkataramanan R, McGhee W, Phillips S, Smith A, Baird C, Iurlano K, Mazariegos G, Cooperstone B, Holt DW, Zeevi A, Fung JJ, Reyes J.
    Transplantation; 2001 Sep 15; 72(5):851-5. PubMed ID: 11571449
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.